Risk of malignancies and chemopreventive effect of statin, metformin, and aspirin in Korean patients with ulcerative colitis: a nationwide population-based study
Intestinal Research · 30.04.2025 · 23 (2) · 129-143
DOI: 10.5217/ir.2023.00062 ↗Kurz gefasst
Fachartikel in der Zeitschrift Intestinal Research, erschienen am 30.04.2025. Verfasst von Eun Hye Oh und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Korea. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Korean Society of Gastroenterology.
Abstract (Originalsprache)
Background/Aims: We investigated the incidences of overall and site-specific malignancies and chemopreventive effects of statin, metformin, and aspirin in patients with ulcerative colitis.
Methods
We collected data using the Health Insurance Review and Assessment claims database from January 2007 to April 2020.
Results
The overall malignancy risk among the 35,189 ulcerative colitis patients was similar to that of the general population (standardized incidence ratio, 0.94; 95% confidence interval, 0.88–1.00). In male patients, standardized incidence ratios were high for thyroid cancer and low for stomach cancer, colorectal cancer, liver cancer, and lung cancer. Concurrently, standard incidence ratios were high for liver cancer and central nervous system cancer in female patients. While 122 cases of colorectal cancer occurred in the study patients, the standardized incidence ratio was 0.83 (95% confidence interval, 0.69–0.99). Treatment for ulcerative colitis was not associated with an increased adjusted hazard ratio, while comorbidities increased it for all malignancies. Treatment for ulcerative colitis was associated with an increased adjusted hazard ratio, while comorbidities did not increase it for colorectal cancer. After adjusting for age, sex, comorbidities, and ulcerative colitis treatment, statins showed a dose-dependent chemopreventive effect for all malignancies (P=0.002), while metformin and aspirin did not show any.
Conclusions
In ulcerative colitis patients, standardized incidence ratios for all malignancies and colorectal cancer did not increase. Adjusted hazard ratios for all malignancies increased with comorbidities and those for colorectal cancer with ulcerative colitis treatment. Statins have a dose-dependent chemopreventive effect for all malignancies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Korea.
- Department of Clinical Epidemiology and Biostatistics, University of Ulsan College of Medicine, Seoul, Korea.
- Department of Gastroenterology, Inje University Haeundae Paik Hospital, Inje University College of Medicine, Busan, Korea.
- Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Förderung
- Korean Society of Gastroenterology
Zitieren
APA
Oh, E. H., Kim, Y. J., Kim, M., Park, S. H., Kim, T. O., & Park, S. H. (2025). Risk of malignancies and chemopreventive effect of statin, metformin, and aspirin in Korean patients with ulcerative colitis: a nationwide population-based study. Intestinal Research, 23(2), 129-143. https://doi.org/10.5217/ir.2023.00062
Vancouver
Oh EH, Kim YJ, Kim M, Park SH, Kim TO, Park SH. Risk of malignancies and chemopreventive effect of statin, metformin, and aspirin in Korean patients with ulcerative colitis: a nationwide population-based study. Intestinal Research. 2025;23(2):129-143. doi:10.5217/ir.2023.00062
BibTeX
@article{Oh2025,
author = {Oh, Eun Hye and Kim, Ye-Jee and Kim, Minju and Park, Seung Ha and Kim, Tae Oh and Park, Sang Hyoung},
title = {Risk of malignancies and chemopreventive effect of statin, metformin, and aspirin in Korean patients with ulcerative colitis: a nationwide population-based study},
journal = {Intestinal Research},
year = {2025},
volume = {23},
number = {2},
pages = {129--143},
doi = {10.5217/ir.2023.00062}
}
EUVIMED